These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 16499995

  • 21. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS, Lee SJ, Choi JE, Cha SI, Lee EB, Park TI, Kim CH, Lee WK, Kam S, Choi JY, Kang YM, Park RW, Kim IS, Cho YL, Jung TH, Han SB, Park JY.
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [Abstract] [Full Text] [Related]

  • 22. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
    Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L, Dong Z, Kuang G.
    Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis.
    Boldrini L, Gisfredi S, Ursino S, Lucchi M, Greco G, Mussi A, Donati V, Fontanini G.
    Cancer Invest; 2008 Mar; 26(2):168-72. PubMed ID: 18259947
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].
    Szymanowska A, Jassem E, Dziadziuszko R, Skrzypski M, Kobierska-Gulida G, Holm K, Borg A, Rzyman W, Limon J, Jassem J.
    Pneumonol Alergol Pol; 2005 Mar; 73(3):264-9. PubMed ID: 16989164
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M, Morán Y, Camargo ME, Rivero MB, Bohórquez A, Villegas V, Ramírez E, Rendón Y, Suárez A, Morales L, Useche E, Salazar S, Zambrano A, Ramírez A, Valderrama E, Briceño Z, Chiurillo MA.
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.
    Hsieh YS, Lee YL, Yang SF, Yang JS, Chen W, Chen SC, Shih CM.
    Lung Cancer; 2007 Nov; 58(2):191-5. PubMed ID: 17688968
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM, Shun CT, Wu MT, Chen YY, Yang SY, Hung HI, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC.
    Mutat Res; 2006 Feb 22; 594(1-2):181-8. PubMed ID: 16318864
    [Abstract] [Full Text] [Related]

  • 38. TP53 codon 72 polymorphism in oral squamous cell carcinoma.
    Drummond SN, De Marco L, Pordeus Ide A, Barbosa AA, Gomez RS.
    Anticancer Res; 2002 Feb 22; 22(6A):3379-81. PubMed ID: 12530090
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.